Alonso F, Boittin FX, Bény JL, Haefliger JA. Loss of connexin40 is associated with decreased endothelium-dependent relaxations and eNOS levels in the mouse aorta. Am J Physiol Heart Circ Physiol 299: H1365-H1373, 2010. First published August 27, 2010; doi:10.1152/ajpheart.00029.2010.-Upon agonist stimulation, endothelial cells trigger smooth muscle relaxation through the release of relaxing factors such as nitric oxide (NO). Endothelial cells of mouse aorta are interconnected by gap junctions made of connexin40 (Cx40) and connexin37 (Cx37), allowing the exchange of signaling molecules to coordinate their activity. Wild-type (Cx40 ϩ/ϩ ) and hypertensive Cx40-deficient mice (Cx40 Ϫ/Ϫ ), which also exhibit a marked decrease of Cx37 in the endothelium, were used to investigate the link between the expression of endothelial connexins (Cx40 and Cx37) and endothelial nitric oxide synthase (eNOS) expression and function in the mouse aorta. With the use of isometric tension measurements in aortic rings precontracted with U-46619, a stable thromboxane A2 mimetic, we first demonstrate that ACh-and ATPinduced endothelium-dependent relaxations solely depend on NO release in both Cx40 ϩ/ϩ and Cx40 Ϫ/Ϫ mice, but are markedly weaker in Cx40 Ϫ/Ϫ mice. Consistently, both basal and ACh-or ATP-induced NO production were decreased in the aorta of Cx40 Ϫ/Ϫ mice. Altered relaxations and NO release from aorta of Cx40 Ϫ/Ϫ mice were associated with lower expression levels of eNOS in the aortic endothelium of Cx40 Ϫ/Ϫ mice. Using immunoprecipitation and in situ ligation assay, we further demonstrate that eNOS, Cx40, and Cx37 tightly interact with each other at intercellular junctions in the aortic endothelium of Cx40 ϩ/ϩ mice, suggesting that the absence of Cx40 in association with altered Cx37 levels in endothelial cells from Cx40 Ϫ/Ϫ mice participate to the decreased levels of eNOS. Altogether, our data suggest that the endothelial connexins may participate in the control of eNOS expression levels and function. connexin40; connexin37; endothelium-dependent relaxation; endothelial nitric oxide synthase
connexin40; connexin37; endothelium-dependent relaxation; endothelial nitric oxide synthase THE ENDOTHELIUM OF BLOOD VESSELS controls smooth muscle tone and arterial blood pressure. In response to agonist stimulation of endothelial cells, a subsequent relaxation of smooth muscle cells occurs. Indeed agonists such as ACh or ATP can stimulate the production of endothelium-derived vasodilators such as nitric oxide (NO), prostacyclin, and the endothelium-derived hyperpolarizing factor (EDHF) depending on the vascular bed (10, 15, 17, 42) .
Intercellular communication between endothelial cells through gap junctions is fundamental for the coordination of vasomotor responses and the control of vascular tone and arterial blood pressure (15, 22) . Endothelial cells are connected by gap junctions, allowing the exchange of ions, second messengers, or metabolites and the spreading of hyperpolarization between adjacent cells (10, 13, 15, 23) .
Gap junction channels connecting the cytosol of adjacent endothelial cells are composed of two connexons formed by six connexin proteins, and the association of two connexons in the plasma membrane of adjacent cells provides a functional gap junction channel that enables cell-to-cell communication (10, 15, 22) . Among the 20 different connexin types, four are expressed in the cardiovascular system (Cx40, Cx37, Cx43, and Cx45), but their expression shows significant variations in different vascular beds or species (10, 15, 22, 41) . In endothelial cells of mice, Cx40 and Cx37 are predominantly expressed, although the expression of Cx43 has also been reported in a few cases (22, 26, 33, 35, 39) . Cx40 has been demonstrated to play a significant role in the interendothelial cell communication, since functional gap junctions formed in part by Cx40 enable the diffusion of dyes in native aortic endothelium (33, 39) . Endothelial gap junctions composed in part by Cx40 have also been shown to allow the spreading of hyperpolarization in the endothelium and the resulting conduction of vasodilation in resistance vessels, whose agonists-induced endothelium-dependent relaxation depends on both EDHF and NO release (11, 14, 16, 46) . However, the link between endothelial connexins (Cx40 and Cx37) and endothelial nitric oxide synthase (eNOS) has not been investigated so far. Using Cx40 Ϫ/Ϫ and Cx40 ϩ/ϩ mice, we tested the hypothesis that Cx40 deficiency and altered Cx37 expression in the endothelium of Cx40 Ϫ/Ϫ mice may alter eNOS expression and function. We show that Cx40 deficiency and altered Cx37 expression in the endothelium of Cx40 Ϫ/Ϫ mice is associated with impaired endothelium-dependent relaxations, NO release, and eNOS expression in the endothelium. We then demonstrate that eNOS, Cx40, and Cx37 tightly interact with each other at intercellular junctions in the aortic endothelium of Cx40 ϩ/ϩ mice. Therefore, reduced expression levels of eNOS in the aortic endothelium of Cx40 Ϫ/Ϫ mice may be directly associated with the absence of Cx40 and marked decrease in the levels of Cx37. Altogether, our results suggest that Cx40 and Cx37, by directly interacting with eNOS, may participate in the control of eNOS expression and function.
MATERIALS AND METHODS

Animals. Cx40
Ϫ/Ϫ mice were a gift from Dr. K. Willecke (29) . Breeding pairs of Cx40 Ϫ/Ϫ mice were crossed with control C57/Bl6 partners. Cx40
Ϫ/Ϫ and Cx40 ϩ/ϩ mice were then identified using PCR of genomic DNA. Primers used for PCR were as follow: for the Cx40 recombinant allele (494 bp), 5=-GGATCGGCCATTGAACAAGAT-GGATTGCAC-3= (sense) and 5=-CTGATGCTCTTCGTCCAGAT-CATCCTGATCG-3= (antisense); for the Cx40 wild-type allele (314 bp), 5=-GGGAGATGAGCAGGCCGACTTCCGGTGCG-3= (sense) and 5=-GTAGGGTGCCCTGGAGGACAATCTTCCC-3= (antisense). Mice used in the experiments were from litters obtained after at least 10 backcrosses into the C57/Bl6 background. Males of three-to five-month-old Cx40 Ϫ/Ϫ and Cx40 ϩ/ϩ mice were used for all experiments. Cx40
Ϫ/Ϫ and Cx40 ϩ/ϩ mice were housed in pathogen-free conditions that conformed to institutional guidelines (animal experimentation authorization 31.1.1008/1993/I). Mouse care, surgery, and euthanasia procedures were approved by our institutional committee for animal experiments, and the veterinary office (Lausanne, Switzerland).
Chemicals. ACh and ATP were from Sigma. U-46619 (9,11-dideoxy-9,11-methanoepoxyprostaglandin F 2) was obtained from Cayman Chemicals. DEA NONOate (DEA/NO) and N G -nitro-L-arginine (L-NA) were from Alexis Biochemicals.
Isometric tension measurements. After being anesthetized with 2-bromo-2-chloro-1,1,1-trifluoroethane, mice were killed by cervical dislocation, and the thoracic aorta was quickly removed and cleaned. Aortic rings of ϳ2 mm were cut in the middle part of the thoracic aorta for isometric tension measurements. Changes in tension of mouse thoracic aortic rings were measured as previously described (4) . Aortic rings do not exhibit vasomotor tone unless stimulated to induce smooth muscle contraction. Basal tension of aortic rings was set to 1 mN. Aortic rings from Cx40 Ϫ/Ϫ and Cx40 ϩ/ϩ mice were contracted with U-46619 (10 Ϫ7 M), a stable thromboxane A2 mimetic. U-46619-induced vasoconstriction was measured before relaxation experiments and expressed in milliNewtons. After reaching a stable contraction plateau, relaxations to ACh (10 Ϫ9 to 10 Ϫ5 M), ATP (3 ϫ 10 Ϫ6 M), or the NO donor DEA/NO (10 Ϫ9 to 10 Ϫ5 M) were recorded. The amplitude of relaxations was not influenced by the degree of vasoconstriction. Relaxation responses to ACh, ATP, and DEA/NO are expressed as the percent of aortic ring contraction to U-46619. To investigate the effect of L-NA on ACh-or ATP-induced endotheliumdependent relaxations, U-46619-precontracted aortic rings were incubated for 30 min with L-NA (100 M) before measurement of the endothelium-dependent relaxations in the continuous presence of the inhibitor. All experiments were performed at 37°C.
Analysis of eNOS activity by nitrite measurements. To evaluate eNOS activity in aortas of Cx40 ϩ/ϩ and Cx40 Ϫ/Ϫ mice, NO production was analyzed by quantifying the reduction levels of nitrate into nitrite (7) . For measurements of the accumulation of secreted NO by aortas, two freshly excised aortas were longitudinally opened in PBS prewarmed at 37°C, pinned on silicone (endothelial cells up), washed three times with PBS, and further incubated for 30 min at 37°C in 200 l of PBS in the absence or presence of 10 Ϫ6 M ACh or 10 Ϫ6 M ATP. To investigate the effect of L-NA on ACh-or ATP-induced NO secretion, aortic strips were incubated for 30 min with L-NA (100 M) before stimulation of NO secretion with ACh or ATP in the continuous presence of the inhibitor. Nitrite released was measured in duplicate by colorimetry (optical density at 540 nm), according to the manufacturer's instructions (Quantichrom Nitric Oxide Assay Kit, DINO-250; BioAssays Systems). For each aorta, total protein content was determined using the DC protein assay reagent kit (Bio-Rad Laboratories) for normalizing the nitrite concentrations.
Western blotting. To prepare enriched endothelial cells samples, aortas were longitudinally opened in 100 l PBS and pinned on silicone, endothelium-side up. A scalpel was used to gently scrape off endothelial cells. Aliquots of endothelial cells were homogenized in SDS Lysis Buffer. Samples were equally loaded (50 g) on a 10% polyacrylamide gel followed by electrophoresis and transferred onto polyvinylidene difluoride membrane (Immobilon-P; Millipore, Volketswil, Switzerland). Membranes were incubated for 1 h in PBS containing 5% milk and 0.1% Tween 20 (blocking buffer RT-PCR analysis. Freshly scraped endothelial cells were homogenized in Tripure Isolation Reagent (Roche). RNA was extracted and analyzed by quantitative real-time PCR as previously reported (31, 32, 36) . Briefly, quantitative real-time PCR was performed on total RNA treated 30 min in the presence of DNase I (DNA-free kit; Ambion, Cambridge, UK), using the SYBR-Premix ExTaq (Takara) in a Lightcycler Instrument (Roche Diagnostics) (1) . Negative controls included amplification of distilled water and RNA samples that had not been reverse transcribed. Analysis of data was performed using the 3.5 version of the Light cycler software (Roche Diagnostics). cDNAs were amplified using the following mouse primers: for eNOS (107 bp), 5=-GGCTGGGTTTAGGGCTGT-3= (sense) and 5=-GCT-GTGGTCTGGTGCTGGT-3= (antisense); for ␤-actin (176 bp), 5=-CGTTGACATCCGTAAAGACC-3= (sense) and 5=-TGGAGCCAC-CGATCCACACA-3= (antisense); for von Willebrand factor (131 bp), 5=-GATGCCCCAGTCAGCTCTAC-3= (sense) and 5=-TCAGCCTCG-GACAACATAGA-3= (antisense).
Immunoprecipitation. Enriched endothelial cell samples prepared as described in Western blotting were homogenized in 1ϫ lysis buffer (10 mM Tris, pH 7.5; 150 mM NaCl; 1 mM EDTA; 1 mM EGTA; 1% Triton X-100; 2.5 mM sodium pyrophosphate; 1 mM ␤-glycerophosphate; 1 mM Na 3VO4; 1 g/ml aprotinin; and 1 g/ml leupeptin) and precleared by incubation with protein A-Sepharose (Zymed) beads for ϳ6 h at 4°C. The cleared lysates were transferred to a fresh tube and incubated with either 2 g of polyclonal anti-mouse Cx40 antibodies [AB1726; Chemicon (38)], 2 g of polyclonal anti-mouse Cx37 antibodies [Cx37A11-A; Biotrend Chemikalien (38)], 2 g of monoclonal antibodies against eNOS [610297; BD Transduction Laboratories (34)], or 2 g of preimmune IgG (Millipore, Billerica, MA) during 20 h at 4°C. eNOS and connexin-containing complexes were captured with a mixture of 20 l of protein A-Sepharose (Zymed) beads for 3 h at 4°C. After incubation, the Sepharose beads were washed three times with 1ϫ lysis buffer, before removal of bound protein by boiling in SDS sample buffer. Samples were resolved in polyacrylamide gel by electrophoresis and analyzed by Western blot probed with various antibodies. Saturated blots were incubated overnight at 4°C in blocking solution containing the following primary antibodies: monoclonal anti-mouse eNOS (610297, 1:1,000; BD Transduction Laboratories) and polyclonal anti-mouse Cx40 (AB1726, 1:250; Chemicon). Bound antibodies were detected with peroxidaseconjugated secondary antibodies (1:20,000; Fluka Chemie) and visualized using enhanced chemiluminescence Western blotting detection reagent (Amersham Bioscience Europe).
Immunostaining and in situ proximity ligation assay. Aortas were opened longitudinally and 2-to 3-mm-long aortic strips were clamped horizontally with micropins (endothelial cells up) on Sylgard-coated dishes. Aortic strips were fixed for 10 min in 100% ethanol at Ϫ20°C, preincubated for 30 min at room temperature with a blocking solution (PBS 0.5% BSA 0.2% Triton X-100), and labeled for Cx40 [AB1726, 1:50; Chemicon (38) ] or Cx37 [Cx37A11-A, 1:50; Biotrend Chemikalien (38) ]. Primary antibodies were detected using anti-rabbit immunoglobulins labeled with fluorescein isothiocyanate (Biosystem).
After Cx37 or Cx40 immunostaining, we used the Duolink in situ proximity ligation assay (OLINK Bioscience) for the visualization of a direct protein interaction between eNOS and Cx40 or Cx37 in the en face aortic strips (27, 40) . Cx37-or Cx40-immunostained aortic strips were incubated, respectively, in the presence of two primary antibodies from different species directed against Cx40 (AB1726; Chemicon) or Cx37 (Cx37A11-A; Biotrend Chemikalien) and eNOS (610297; BD Transduction Laboratories) diluted 1:50. Two secondary antibodies, to which oligonucleotides have been attached, were used to detect the target proteins. If the target proteins are in proximity, the attached oligonucleotides are also brought in close proximity and can then be used as a template for the DNA ligase-mediated joining of two additional linear oligonucleotides, causing them to form a circular DNA molecule. By using one of the antibody-attached oligonucleotides as a primer, the circular DNA molecule was amplified into a long single-stranded concatemer by rolling circle amplification. The rolling circle amplification product collapsed into a bundle of DNA that was detected by hybridizing fluorophore-labeled oligonucleotides to the repeated sequences in the amplification product and were detected by fluorescence microscopy as bright submicrometer-sized spots (30) . For Cx40/Cx37 double immunostaining in aortic endothelium, as well as for the visualization of a direct protein interaction between Cx40 and Cx37 in the en face aortic strips, a monoclonal antibody specific to mouse Cx40 was used (37-8900, 1:200; Invitrogen) and was detected using anti-mouse immunoglobulins labeled with Alexafluor 594 (Invitrogen).
Statistical analysis. 
RESULTS
ACh-and ATP-induced endothelium-dependent relaxations are impaired in Cx40
Ϫ/Ϫ mice. Aortic rings from both Cx40 ϩ/ϩ and Cx40 Ϫ/Ϫ mice with intact endothelium were first preconstricted with U-46619 (10 Ϫ7 M), a stable thromboxane A 2 mimetic, and endothelium-dependent relaxations triggered by increasing ACh concentrations were recorded. U-46619-induced constriction was increased in aortic rings from Cx40 Ϫ/Ϫ mice compared with Cx40 ϩ/ϩ mice (Fig. 1, A and B) . As shown in Fig. 1 , A and C, the amplitude of ACh-induced endothelium-dependent relaxations was significantly altered in aortic rings from Cx40 Ϫ/Ϫ compared with those of Cx40
mice, when expressed in percent of U-46619-induced contraction. Indeed, for the full range of ACh concentrations tested, the endothelium-dependent relaxations were significantly lower by ϳ40 -50% in aortic rings from Cx40 Ϫ/Ϫ mice. Similar results were found when ACh-induced endothelium-dependent relaxations were expressed in milliNewtons rather than normalized to U-46619-induced contraction (data not shown).
In both Cx40
ϩ/ϩ and Cx40 Ϫ/Ϫ mice, ACh-induced relaxations were abolished upon eNOS inhibition with L-NA (Fig. 1C) , as previously reported for Cx40 ϩ/ϩ mice (4, 8) . In U-46619-precontracted aortic rings, bath addition of L-NA further increased U-46619-induced tension in both Cx40 ϩ/ϩ and Cx40 Ϫ/Ϫ mice by 11.4 Ϯ 1% for Cx40 ϩ/ϩ mice (n ϭ 6 rings) and by 5.7 Ϯ 1.7% (n ϭ 8 rings) for Cx40 Ϫ/Ϫ mice. However, the L-NA-induced increase in tension was significantly higher for Cx40 ϩ/ϩ mice compared with Cx40 Ϫ/Ϫ mice (P Ͻ 0.05). Similar results were obtained when endothelium-dependent relaxations were triggered by ATP, another agonist that acts on the endothelium to trigger NO release and relaxation of smooth muscle (3, 5) . Indeed, the ATP-induced endothelium-dependent relaxation was significantly altered by ϳ50% in aortic rings from Cx40 Ϫ/Ϫ compared with those of Cx40 ϩ/ϩ mice and was abolished upon eNOS inhibition with L-NA in both cases (Fig. 1D) . To investigate whether the altered ACh-and ATP-induced relaxations of Cx40 Ϫ/Ϫ mice may be related to the potency of NO to relax smooth muscle, we compared the endothelium-independent relaxations triggered by a NO donor (DEA/NO) in aortic rings of Cx40 Ϫ/Ϫ and Cx40 ϩ/ϩ mice precontracted with U-46619 (10 Ϫ7 M). Figure 1E shows that the amplitudes of the endothelium-independent relaxations triggered by DEA/NO were not significantly different in aortic rings from Cx40 Ϫ/Ϫ and Cx40 ϩ/ϩ mice, whatever the concentration of the NO donor. These results indicate that the decreased ACh-and ATP-induced relaxations observed in aortic rings lacking Cx40 are not associated with a weaker potency of smooth muscle to relax in response to NO. Our results indicate that the ACh-and ATP-induced endothelium-dependent relaxations are markedly weaker in the mouse aorta of Cx40 Ϫ/Ϫ mice and solely depend on NO release by eNOS for both Cx40 ϩ/ϩ and Cx40 Ϫ/Ϫ mice.
NO release by the aorta of Cx40
ϩ/ϩ and Cx40 Ϫ/Ϫ mice. The accumulation of nitrite in the medium was measured to assess the NO release by the aorta of Cx40 ϩ/ϩ and Cx40 Ϫ/Ϫ mice. In the absence of any stimuli, nitrite accumulation in the medium due to basal NO release by the aortic cells was significantly lower in the Cx40 Ϫ/Ϫ aorta compared with Cx40 ϩ/ϩ aorta (Fig. 2) . Upon ACh or ATP stimulation, nitrite production by the aortic cells was increased for both Cx40 ϩ/ϩ and Cx40 Ϫ/Ϫ aortas. ACh-or ATP-induced nitrite accumulation was solely due to NO release by eNOS, since it was completely blocked upon eNOS inhibition by L-NA. However, nitrite production was significantly higher in the aorta of Cx40 ϩ/ϩ mice compared with the levels observed in Cx40 Ϫ/Ϫ aorta upon ACh or ATP stimulation (Fig. 2) . Altogether, these results indicate that both basal and ACh-or ATP-stimulated NO release is impaired in the aorta of Cx40 Ϫ/Ϫ mice. To investigate whether the altered endothelium-dependent relaxations and NO release of the Cx40 Ϫ/Ϫ aorta may be related to eNOS expression, we compared eNOS expression levels in the aortic endothelium of Cx40 ϩ/ϩ and Cx40
Expression of eNOS is decreased in the aortic endothelium of Cx40
Ϫ/Ϫ mice. eNOS expression levels were assessed using Western blot analysis of an enriched fraction of freshly scraped aortic endothelium of Cx40 ϩ/ϩ and Cx40 Ϫ/Ϫ mice. The antieNOS antibodies recognized a specific immunolabeled band around 130 kDa (Fig. 3A) corresponding to the reported molecular mass of murine eNOS (19, 34) . Densitometric analysis revealed that eNOS expression levels were reduced by ϳ40% in the aortic endothelium of Cx40 Ϫ/Ϫ mice compared with Cx40 ϩ/ϩ mice (Fig. 3A) . To investigate the molecular mechanisms involved in the downregulation of eNOS in the aortic endothelium of Cx40 Ϫ/Ϫ mice, we measured eNOS mRNA levels in enriched fractions of freshly scraped aortic endothelium from Cx40 Ϫ/Ϫ and Cx40 ϩ/ϩ mice. eNOS mRNA levels were similar in the endothelium of Cx40 Ϫ/Ϫ and Cx40 ϩ/ϩ mice, indicating that the downregulation of eNOS in the aortic endothelium lacking Cx40 is due to posttranscriptional mechanisms (Fig. 3B) .
eNOS interacts with Cx40 and Cx37 in the aortic endothelium of Cx40
ϩ/ϩ mice. Western blot analysis of an enriched fraction of freshly scraped aortic endothelium from Cx40 ϩ/ϩ mice revealed that the anti-Cx40 and -Cx37 antibodies, respectively, recognized specific immunolabeled bands of ϳ40 and ϳ37 kDa corresponding to the reported molecular masses of Cx40 and Cx37 (Fig. 4A) (24, 45) . As expected, Cx40-immunolabeled band was absent, whereas Cx37 expression levels were decreased about twofold in the aortic endothelium of Cx40 Ϫ/Ϫ mice ( Fig. 4A) (32, 39) . Consistently, double-labeling performed in en face preparations demonstrated that Cx40 and Cx37 are colocalized in the aortic endothelium from Cx40 ϩ/ϩ mice, although, as expected, only Cx37 was detected in the aortic endothelium from Cx40 Ϫ/Ϫ mice (Fig. 4B ). To determine whether the decreased eNOS levels may be linked to the absence of Cx40 expression and/or decreased levels of Cx37, we performed immunoprecipitation experiments to investigate a putative association between eNOS, Cx40, and Cx37. An enriched preparation of freshly scraped aortic endothelium from both Cx40 ϩ/ϩ and Cx40 Ϫ/Ϫ mice (input) was first incubated in the presence of anti-Cx40 or -Cx37 antibodies (Fig. 4C) . The immune complexes were collected using protein A-Sepharose beads and analyzed by immunoblotting using eNOS antibodies. Figure 4C (top) shows that eNOS interacts with both Cx40 (IP Cx40 lane) and Cx37 (IP Cx37 lane) in the aortic endothelium of Cx40 ϩ/ϩ mice. In contrast, in the aortic endothelium of Cx40 Ϫ/Ϫ mice, eNOS was not detectable in the presence of anti-Cx40 antibodies (IP Cx40 lane), whereas eNOS was immunoprecipitated to a lower extent than observed in Cx40 ϩ/ϩ endothelium using anti-Cx37 antibodies (IP Cx37 lane, Fig. 4C, top) due to decreased Cx37 levels in the endothelium of Cx40 Ϫ/Ϫ mice (Fig. 4A) . With the use of specific antibodies against Cx40, Western blot analysis revealed the presence of Cx40 in the endothelium of Cx40 ϩ/ϩ mice but not in Cx40 Ϫ/Ϫ mice among the proteins immunoprecipitated with specific eNOS or Cx37 antibodies (Fig. 4C,  bottom) . These results demonstrate that eNOS specifically interacts with Cx40 and Cx37 and also indicate that Cx40 and Cx37 closely interact together. As expected, the eNOS-Cx40 and Cx40-Cx37 immunoprecipitated complexes were absent in the aortic endothelium of Cx40 Ϫ/Ϫ mice. Positive controls included samples of whole aortas of Cx40 ϩ/ϩ mice (aorta lane)
as well as samples of freshly scraped aortic endothelium (input) used for the immunoprecipitation procedure. These results suggest that eNOS, Cx40, and Cx37 are tightly associated in endothelial cells of mouse aorta.
To determine the subcellular interaction between eNOS, Cx40, and Cx37, we performed the proximity ligation methodology using oligonucleotide-conjugated secondary antibodies that, when in close proximity, allow an in situ polymerization reaction. This is a sensitive method to detect protein-protein interaction in intact tissue (27, 30, 40) . Combining eNOS antibodies with Cx40 antibodies resulted in the detection of Texas red-labeled products (red bright submicrometer-sized spots) when observed in en face aortic preparations, demonstrating that eNOS and Cx40 were tightly associated in the intact endothelium (nucleus of endothelial cells were visualized by Hoechst staining) from Cx40 ϩ/ϩ mice and form endogenous molecular complexes (Fig. 5A, top) . Moreover, immunostaining of Cx37 in the same en face aortic preparation revealed that Cx40/eNOS complexes are mainly located at or in the vicinity of the intercellular junctions between endothelial cells (33, 39) (Fig. 5A, top) . Similar observations were made for Cx37 and eNOS, since immunostaining of Cx40 on the same en face aortic preparation revealed that Cx37/eNOS complexes are also mainly located at or in the vicinity of the intercellular junctions (33, 39) (Fig. 5A, middle) . Figure 5A , bottom, represents negative controls, since only one of the primary antibodies was added on the en face aortic preparation before the proximity ligation assay.
Combining Cx40 with Cx37 antibodies revealed endogenous molecular complexes in the aortic endothelium from Cx40 ϩ/ϩ mice, demonstrating that Cx40 and Cx37 are linked, as expected from the colocalization of Cx37 and Cx40 previously observed by immunostaining (Fig. 5B) . Consistently, neither Cx40-Cx37 nor Cx40-eNOS molecular complexes were detected in the aortic endothelium of Cx40 Ϫ/Ϫ mice, whereas combining eNOS antibodies with Cx37 antibodies hardly revealed Cx37-eNOS complexes in the endothelium of Cx40 Ϫ/Ϫ mice (Fig. 5 , B and C) due to marked decrease of Cx37 (Fig. 4) .
Altogether, the data presented in Figs. 4 and 5 clearly demonstrate that Cx40, Cx37, and eNOS are tightly associated and form endogenous molecular complexes at intercellular junctions in endothelial cells from Cx40 ϩ/ϩ mice.
DISCUSSION
Using Cx40
Ϫ/Ϫ and Cx40 ϩ/ϩ mice, we investigated the link between the expression of endothelial connexins (Cx40 and Cx37) and eNOS expression and function in the mouse aorta. We demonstrate that the ACh-and ATP-induced endotheliumdependent relaxations are markedly weaker in the aorta of Cx40 Ϫ/Ϫ mice. In both Cx40 ϩ/ϩ and Cx40 Ϫ/Ϫ mice, ACh-and ATP-induced endothelium-dependent relaxations were abolished by eNOS inhibition. These observations indicate that, in both Cx40 ϩ/ϩ and Cx40 Ϫ/Ϫ mice, ACh-and ATP-induced endothelium-dependent relaxations solely depend on NO release, as previously demonstrated in Cx40 ϩ/ϩ mice (3) (4) (5) 8) . ACh and ATP use distinct receptors to trigger NO release and smooth muscle relaxation. ACh-induced endothelium-dependent relaxation is mediated through the activation of M 3 muscarinic ACh receptors, whereas ATP-induced relaxation depends on P2Y receptor activation (3, 4, 28) . The similar alteration of ACh-and ATP-induced endothelium-dependent relaxations observed in Cx40 Ϫ/Ϫ mice (ϳ50% decrease) demonstrates that the relaxation defect of these mice is not specific to a mediator and suggests a shared explanation. Indeed, the altered ACh-and ATP-induced relaxations observed in Cx40 Ϫ/Ϫ mice are likely to be related to the marked decrease of NO release observed upon ACh or ATP stimulation, since we found that the sensitivity of smooth muscle to exogenous NO was unaffected in Cx40 Ϫ/Ϫ mice. The reduced basal and ACh/ATP-stimulated NO release of Cx40 Ϫ/Ϫ mice are most likely associated with the altered eNOS expression levels observed in the endothelium of these mice. The increase in U-46619-induced constriction we found in Cx40 Ϫ/Ϫ mice may be related to the altered basal NO release in the aorta from Cx40 Ϫ/Ϫ mice. Moreover, the lower increase of U-46619-induced contraction triggered by eNOS blockade in Cx40 Ϫ/Ϫ mice is likely explained by the altered basal NO release we found in these mice. Altogether, these results suggest that a basal activity of eNOS controls aortic tone upon U-46619-induced contraction and also that the impaired eNOS expression and NO release of Cx40 Ϫ/Ϫ mice results in altered control of vasomotor tone in the aorta.
The downregulation of eNOS in the aortic endothelium of Cx40 Ϫ/Ϫ mice is due to posttranscriptional mechanisms, since similar eNOS mRNA levels were detected in the aortic endothelium from Cx40 ϩ/ϩ and Cx40 Ϫ/Ϫ mice. Immunoprecipitation and in situ proximity ligation assays associated with Cx40 or Cx37 immunostainings demonstrate that eNOS, Cx40, and Cx37 interact with each other at intercellular junctions of endothelial cells from Cx40 ϩ/ϩ mice, in accordance with a recent paper demonstrating that Cx37 interacts with eNOS in endothelial cells (37) . The in situ proximity ligation assay analysis also provides evidence that the maximal distance Fig. 5 . Detection of an association between connexins and eNOS. A: for the visualization of the direct protein interaction between eNOS, Cx40, and Cx37 in the endothelial cells of aortas, the fixed vessel was opened longitudinally and incubated in the presence of two primary antibodies directed against Cx40 or Cx37 and eNOS. Two secondary antibodies, to which oligonucleotides were attached, allowed the detection of the target proteins. Because Cx40 (panel Cx40/eNOS) or Cx37 (panel Cx37/eNOS) are in proximity of eNOS, the attached oligonucleotides constitute a template to form a circular DNA molecule that was amplified to form a bundle of DNA detected by a Texas red-labeled probe (red spots). The first row of images shows, respectively, from left to right in situ ligation assay for Cx40 and eNOS in an aortic en face preparation together with endothelial nucleus staining with Hoechst, immunostaining for Cx37 in the same en face preparation, and a merge of both images. The second row of images shows, respectively, from left to right in situ ligation assay for Cx37 and eNOS in an aortic en face preparation together with nucleus staining with Hoechst, immunostaining for Cx40 in the same en face preparation, and a merge of both images. Images in the last row represent negative controls for in situ ligation assay performed by incubation with only one of the following antibodies: the Cx40 antibodies (Cx40), the Cx37 antibodies (Cx37), or the eNOS antibodies (eNOS). Data are representative from 4 independent experiments. B: as a positive control of the in situ ligation assay, a similar experiment has been performed to visualize the direct interaction existing between Cx37 and Cx40 in the membrane of endothelial cells using specific antibodies against Cx40 and Cx37 on an aortic en face preparation of Cx40 ϩ/ϩ (left) and Cx40 Ϫ/Ϫ (right) mice. Data are representative from 3 independent experiments. C: as a negative control, no signal was observed on an aortic en face preparation of Cx40 Ϫ/Ϫ mice using in situ ligation assay performed with specific antibodies against Cx40 and eNOS. Replacement of Cx40 antibodies with Cx37 antibodies allows revealing a weak signal due to lower Cx37 levels in the endothelium of Cx40 Ϫ/Ϫ mice. Data are representative from 3 independent experiments. between eNOS, Cx40, and Cx37 is less than a few tens of nanometers (40) . Therefore, reduced eNOS expression levels in the aortic endothelium of Cx40-deficient mice may be directly related to the absence of Cx40 and the reduced expression levels of Cx37, which is downregulated in the endothelium of Cx40-deficient mice (32, 39) .
Hypertension in Cx40 Ϫ/Ϫ mice is mostly due to an altered secretion of renin, and these mice may represent a genetic model of renin-dependent hypertension (12, 32, 44) . Chronic hypertension results in hypertrophic remodeling of the vessels, including the aorta associated with an adaptation of the arterial walls due to altered hemodynamic conditions (11, 12) in presence of increased plasma levels of renin and angiotensin II (32) . High levels of angiotensin II have previously been linked to reduced eNOS expression, eNOS dysfunction, and mislocalization (18, 20, 25, 43) . Therefore, altered eNOS expression and function of Cx40 Ϫ/Ϫ mice may be related to both the absence of Cx40 associated with decreased Cx37 levels and also to the increased angiotensin II levels found in these animals. However, in contrast to studies showing that angiotensin II reduce eNOS expression through an alteration of eNOS gene expression (reduced mRNA levels) (20, 25) , the levels of eNOS mRNA were not altered in the endothelium of Cx40 Ϫ/Ϫ mice. Therefore, our results show that altered eNOS expression in Cx40
Ϫ/Ϫ mice is mainly due to a posttranscriptional mechanism, which is in favor of a causal link between the marked decrease in connexin expression in the endothelium and reduced eNOS expression levels. Moreover, a recent report suggests a role for Cx37 in regulating eNOS function (37) .
The expression of eNOS and/or the production of NO are altered in many types of cardiovascular diseases such as atherosclerosis, diabetes, and hypertension (9) . Interestingly, the alteration of connexin expression, including Cx40, has also been associated with the development of such vascular diseases (2, 6) . Here, we provide direct evidence for a tight link between Cx40, Cx37, and eNOS at the intercellular junctions of endothelial cells, suggesting that an interplay exists between the alterations of connexin expression and eNOS expression/function occurring in vascular diseases, and also that eNOS function may be partly regulated by connexins, as already observed for other proteins such as calmodulin, caveolin-1, heat shock protein 90, or protein kinase B (21) .
In summary, we have shown that endothelium-dependent relaxations and NO release are altered in the aorta of mice lacking Cx40 due to the downregulation of eNOS levels in the aortic endothelium. We have also demonstrated that eNOS closely interact with Cx40 and Cx37 at the intercellular junctions in the normal aortic endothelium, suggesting that Cx40 deficiency together with altered Cx37 expression may be responsible for eNOS downregulation in the aortic endothelium of Cx40 Ϫ/Ϫ mice. Our study suggests that Cx40 and Cx37 may participate in the control of eNOS expression and function in the aorta. The direct role of endothelial connexins in the regulation of eNOS remains to be investigated.
